COVID-19 and Alzheimer’s disease in the ADNI cohort
Abstract
INTRODUCTION: There is growing evidence that COVID-19 infection in older adults increases the risk of diagnosis of Alzheimer’s disease and accelerates cognitive decline. We hypothesized that participants reporting COVID-19 infection would have greater cognitive and functional decline and greater occurrence of neuropsychiatric symptoms after COVID-19 infection in comparison to uninfected matched controls. METHODS This secondary data analysis from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort examined participants with and without self-reported history of COVID-19 infection comparing visits before and after infection. RESULTS The 16 participants included in the COVID-19 cohort and the 32 controls, had similar changes in cognitive, functionality and behavioral measures between study visits. CONCLUSIONS While there is evidence that COVID-19 infection increases the risk for depression, cognitive changes and conversion to dementia, this examination of a well characterized cohort of at risk and cognitive impaired individuals did not find evidence for the impact of COVID-19 after infection.
Related articles
Related articles are currently not available for this article.